BeStock  

Fulgent Genetics FLGT

US equityMarket cap rank #3662Diagnostics & Research
$20.57 −$0.01 (-0.05%)
Pre-market · Oct 8, 8:20 am ET · After hours $20.57 0.00%
Open$20.48
Prev close$20.58
Day range$19.90 – $20.70
Volume298.3K
Market cap$565.99M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$85.39M+4.4% YoY
Operating profit-$33.90M-72.0% YoY
Net profit-$29.72M-54.3% YoY
Diluted EPS-$1.05-69.4% YoY
Free cash flow-$27.62M+25.4% YoY
Operating cash flow-$23.76M

Revenue, last 8 quarters

$71.7MSep '24$76.2MDec '24$73.5MMar '25$81.8MJun '25$84.1MSep '25$83.3MDec '25$71.1MMar '26$85.4MJun '26

Net profit, last 8 quarters

$-14.7MSep '24$-6.2MDec '24$-11.9MMar '25$-19.3MJun '25$-6.8MSep '25$-23.7MDec '25$-25.3MMar '26$-29.7MJun '26

Diluted EPS by quarter

-0.48Sep '24-0.19Dec '24-0.37Mar '25-0.62Jun '25-0.21Sep '25-0.76Dec '25-0.80Mar '26-1.05Jun '26

Free cash flow by quarter

$-35.0MSep '24$21.2MDec '24$-9.1MMar '25$-37.0MJun '25$5.1MSep '25$-83.1MDec '25$1.9MMar '26$-27.6MJun '26

Annual revenue

$421.7MFY20$992.6MFY21$619.0MFY22$289.2MFY23$283.5MFY24$322.7MFY25

Profitability & balance sheet

Gross margin35.6%
Operating margin-37.1%
Net margin-26.0%
Return on equity-8.0%
Return on assets-7.4%
Return on invested capital-10.5%
Current ratio6.34
Liabilities / assets8.6%
Cash & investments$257.03M
Total debt$7.57M
Net cash (debt)$249.47M

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Laboratory services$85.36M 100.0%
  • Therapeutic Development$30,000.00 0.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $85.39M $71.14M $322.67M $83.34M $84.07M
Total Operating Revenue $85.39M $71.14M $322.67M $83.34M $84.07M
Cost of Revenue $59.71M $49.65M $191.80M $50.75M $48.56M
Gross Profit $25.68M $21.49M $130.88M $32.58M $35.51M
Operating Expense $59.58M $56.11M $221.97M $68.82M $50.86M
Selling and Admin Expenses $42.42M $39.91M $160.04M $52.62M $34.98M
-Selling & Marketing Expense $15.23M $12.22M $43.37M $10.98M $11.64M
-General & Admin Expense $27.20M $27.68M $116.66M $41.65M $23.34M
Research & Development $14.55M $14.18M $53.91M $14.17M $13.86M
Depreciation & Amortization & Depletion $2.60M $2.03M $8.03M $2.03M $2.03M
-Depreciation & Amortization $2.60M $2.03M $8.03M $2.03M $2.03M
Operating Profit -$33.90M -$34.62M -$91.10M -$36.24M -$15.35M
Net Non-Operating Interest Income (Expense) $6.35M $8.63M $30.84M $6.92M $7.85M
Non-Operating Interest Income $6.40M $8.65M $30.92M $6.94M $7.87M
Non-Operating Interest Expense $59,000.00 $17,000.00 $75,000.00 $16,000.00 $28,000.00
Other Income (Expense) -$2.13M $10,000.00 -$9.77M $44,000.00 -$5,000.00
Special Income (Charges) -$2.17M – -$9.93M $0.00 $0.00
-Less:Impairment of Capital Assets $2.17M – $0.00 – –
-Less:Write Off $0.00 – $9.93M $0.00 $0.00
Other Non-Operating Income (Expenses) $38,000.00 $10,000.00 $153,000.00 $44,000.00 -$5,000.00
Pretax Profit -$29.69M -$25.98M -$70.03M -$29.27M -$7.51M
Tax $29,000.00 -$704,000.00 -$8.39M -$5.62M -$683,000.00
Net Profit -$29.72M -$25.27M -$61.63M -$23.65M -$6.83M
Profit from Continuing Operations -$29.72M -$25.27M -$61.63M -$23.65M -$6.83M
Minority Interests -$189,000.00 -$448,000.00 -$1.12M -$232,000.00 -$218,000.00
Net Income to Parent Company -$29.53M -$24.83M -$60.51M -$23.42M -$6.61M
Net Income to Common Stockholders -$29.53M -$24.83M -$60.51M -$23.42M -$6.61M
Basic EPS -$1.05 -$0.80 -$1.97 -$0.76 -$0.21
Diluted EPS -$1.05 -$0.80 -$1.97 -$0.76 -$0.21

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $1.09B $1.16B $1.21B $1.21B $1.21B
Total Current Assets $454.77M $479.04M $550.49M $550.49M $507.37M
Cash and Cash Equivalents & Short-Term Investments $257.03M $276.30M $336.08M $336.08M $375.80M
-Cash and Cash Equivalents $26.31M $23.40M $50.19M $50.19M $117.64M
-Short Term Investments $230.73M $252.90M $285.88M $285.88M $258.16M
Receivables $70.53M $75.74M $91.61M $91.61M $78.72M
-Accounts Receivable $64.94M $69.28M $84.76M $84.76M $71.19M
-Accrued Interest Receivable $4.13M $5.38M $5.71M $5.71M $6.13M
-Other Receivables $1.46M $1.08M $1.13M $1.13M $1.40M
Prepaid Assets $115.55M $114.95M $112.20M $112.20M $42.79M
Inventory $11.67M $12.06M $10.60M $10.60M $10.06M
Total Non-Current Assets $634.45M $677.33M $663.04M $663.04M $707.19M
Net PPE $113.07M $116.34M $112.55M $112.55M $111.87M
-Gross PPE $177.36M $177.65M $170.49M $170.49M $166.06M
-Accumulated Depreciation -$64.30M -$61.31M -$57.95M -$57.95M -$54.20M
Investments and Advances $294.32M $328.29M $369.27M $369.27M $411.78M
-Available for Sale Securities $294.32M $328.29M $369.27M $369.27M $411.78M
Goodwill and Other Intangible Assets $203.12M $207.72M $158.36M $158.36M $160.34M
-Goodwill $53.86M $53.73M $25.08M $25.08M $25.08M
-Other Intangible Assets $149.26M $153.99M $133.28M $133.28M $135.26M
Other Non-Current Assets $23.95M $24.98M $22.86M $22.86M $23.21M
Total Liabilities $93.24M $112.22M $106.81M $106.81M $93.81M
Total Current Liabilities $71.76M $90.13M $84.97M $84.97M $72.43M
Payables $15.56M $21.13M $18.65M $18.65M $18.09M
-Accounts Payable $15.56M $21.13M $18.65M $18.65M $18.09M
Current Accrued Expenses $12.52M $24.39M $22.14M $22.14M $12.53M
Short-Term Debt and Capital Lease Obligation $2.34M $2.41M $1.94M $1.94M $1.96M
-Current Debt $482,000.00 $482,000.00 $476,000.00 $476,000.00 $476,000.00
-Current Capital Lease Obligation $1.86M $1.93M $1.46M $1.46M $1.49M
Current Deferred Liabilities $32.21M $33.63M $31.78M $31.78M $30.85M
Total Non-Current Liabilities $21.48M $22.08M $21.84M $21.84M $21.38M
Long Term Debt and Capital Lease Obligation $7.09M $7.48M $5.74M $5.74M $5.58M
-Long Term Debt $1.48M $1.48M $1.96M $1.96M $1.96M
-Long Term Capital Lease Obligation $5.61M $6.01M $3.78M $3.78M $3.62M
Non-Current Deferred Liabilities $6.89M $6.98M $6.94M $6.94M $7.04M
Other Non-Current Liabilities $7.50M $7.62M $9.17M $9.17M $8.76M
Total Equity $995.99M $1.04B $1.11B $1.11B $1.12B
Stockholders' Equity $1.00B $1.05B $1.11B $1.11B $1.13B
Capital Stock $4,000.00 $4,000.00 $3,000.00 $3,000.00 $3,000.00
-Common Stock $4,000.00 $4,000.00 $3,000.00 $3,000.00 $3,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $524.10M $540.14M $574.52M $574.52M $565.69M
Retained Earnings $475.60M $505.13M $529.95M $529.95M $553.37M
Gains/Losses Not Affecting Retained Earnings $1.92M $4.54M $7.51M $7.51M $6.82M
Minority Interests -$5.63M -$5.66M -$5.27M -$5.27M -$5.13M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$23.76M $7.10M -$101.64M -$78.14M $11.11M
Net cash flow from continuing operations -$23.76M $7.10M -$101.64M -$78.14M $11.11M
Net Income from Continuing Operations -$29.72M -$25.27M -$61.63M -$23.65M -$6.83M
Gain/Loss from Continuing Operations -$71,000.00 -$9,000.00 -$65,000.00 -$41,000.00 -$22,000.00
Depreciation & Depletion & Amortization $7.68M $6.00M $24.12M $6.11M $6.04M
Deferred Tax -$200,000.00 -$921,000.00 -$278,000.00 $395,000.00 -$701,000.00
Other Non-Cash Items $469,000.00 $353,000.00 $1.79M $563,000.00 $486,000.00
Change in Working Capital -$15.63M $16.76M -$117.63M -$71.71M $2.38M
-Change in Receivables $729,000.00 $16.43M -$23.25M -$15.38M $4.91M
-Change in Payables and Accrued Expense -$18.11M -$2.53M $9.46M $13.25M $31.80M
-Change in Other Current Assets $2.28M $2.79M $798,000.00 $1.82M -$1.37M
-Change in Other Current Liabilities -$505,000.00 -$381,000.00 -$1.63M -$446,000.00 -$470,000.00
-Change In Other Working Capital -$28,000.00 $449,000.00 -$103.02M -$70.96M -$32.48M
Net cash flow from investing $50.80M $10.94M $111.37M $11.15M $19.08M
Net Cash Flow from Continuing Investing Activities $50.80M $10.94M $111.37M $11.15M $19.08M
Net PPE Purchase and Sale -$3.86M -$5.19M -$22.57M -$4.98M -$6.05M
Net Business Purchase and Sale $0.00 -$55.57M $3.78M $0.00 $3.78M
Net Investment Purchase and Sale $54.66M $71.70M $130.17M $16.13M $21.36M
Financing Cash Flow -$24.23M -$44.83M -$14.79M -$534,000.00 -$445,000.00
Net Cash Flow from Continuing Financing Activities -$24.23M -$44.83M -$14.79M -$534,000.00 -$445,000.00
Net Issuance Payments Of Debt -$88,000.00 -$564,000.00 -$870,000.00 -$88,000.00 -$88,000.00
Net Common Stock Issuance -$24.14M -$44.28M -$13.92M -$447,000.00 -$357,000.00
Proceeds from Stock Option Exercised $2,000.00 $9,000.00 $1,000.00 – –
Ending Cash Balance $26.44M $23.53M $50.33M $50.33M $117.78M
Net Change in Cash $2.82M -$26.80M -$5.06M -$67.52M $29.75M
Beginning Cash Balance $23.53M $50.33M $55.28M $117.78M $88.02M
Effect of Exchange Rate Changes $88,000.00 $3,000.00 $105,000.00 $75,000.00 $15,000.00
Free Cash Flow -$27.62M $1.90M -$124.21M -$83.12M $5.06M

Discussion

No comments yet — be the first to weigh in on FLGT.

Leave a comment

Scroll to Top